JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Prucalopride (Motegrity; R-108512; R 108512; Resolor; Resotran; R108512; Prudac), a novel enterokinetic compound and the first representative drug of the benzofuran class of laxatives, is a selective and high affinity 5-HT (serotonin) receptor agonist with Kis of 2.5 nM and 8 nM for 5-HT4A and 5-HT4B receptor, respectively. It exhibits > 290-fold selectivity against other 5-HT receptor subtypes. Prucalopride induces contractions in a concentration-dependent manner with pEC50 of 7.5. Prucalopride significantly amplifies the rebound contraction of the guinea-pig proximal colon after electrical field stimulation. Prucalopride was approved by FDA in December 2018 to treat chronic idiopathic constipation.
References: Eur J Pharmacol. 2001 Jun 29; 423(1):71-83; N Engl J Med. 2008 May 29; 358(22):2344-54.
Related CAS#: 179474-85-2 (Succinate); 179474-80-7 (HCl)
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!